- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 24, Issue 4, 2024
Mini Reviews in Medicinal Chemistry - Volume 24, Issue 4, 2024
Volume 24, Issue 4, 2024
-
-
Synthetic and Clinical Perspectives of Evotaz: An Overview
Authors: Sachin Puri, Tanuja T. Yadav, Mangilal Chouhan and Kapil KumarViruses cause a variety of diseases in the human body. Antiviral agents are used to prevent the production of disease-causing viruses. These agents obstruct and kill the virus's translation and replication. Because viruses share the metabolic processes of the majority of host cells, finding targeted medicines for the virus is difficult. In the ongoing search for better antiviral agents, the USFDA approved EVOTAZ, a new drug discovere Read More
-
-
-
Progress in Research on CNPY2 in Diseases
Authors: Ke-qian Chen, Yu-qing Zhang, Zong-bao Wang and Shu-zhi WangCanopy FGF signaling regulator 2 (CNPY2) is a novel angiogenic growth factor. In recent years, increasing evidence highlights that CNPY2 has important functions in health and disease. Many new blood vessels need to be formed to meet the nutrient supply in the process of tumor growth. CNPY2 can participate in the development of tumors by promoting angiogenesis. CNPY2 also enhances neurite outgrowth in neurologic Read More
-
-
-
An Insight into the Combat Strategies for the Treatment of Type 2 Diabetes Mellitus
Authors: Gita Chawla, Tathagata Pradhan and Ojasvi GuptaDiabetes is a chronic, and metabolic disorder that has gained epidemic proportions in the past few decades creating a threat throughout the globe. It is characterized by increased glucose levels that may be due to immune-mediated disorders (T1DM), insulin resistance or inability to produce sufficient insulin by β-pancreatic cells (T2DM), gestational, or an increasingly sedentary lifestyle. The progression of the disease is marke Read More
-
-
-
Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
More LessTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor patient prognosis. In 2018, an estimated 2.1 million new cases of breast cancer were diagnosed globally, with the inci Read More
-
-
-
MiRNAs: Emerging Agents for Therapeutic Effects of Polyphenols on Ovarian Cancer
Authors: Bita Badehnoosh, Nesa Rajabpoor Nikoo, Reza Asemi, Rana Shafabakhsh and Zatollah AsemiIn terms of female reproductive tract cancers, ovarian cancer remains the principal reason for mortality globally and is notably difficult to identify in its early stages. This fact highlights the critical need to establish prevention strategies for patients with ovarian cancer, look for new robust diagnostic and prognostic markers, and identify potential targets of response to treatment. MicroRNAs (miRNAs) are one of the novel tre Read More
-
-
-
Mechanism of Action of Collagen and Epidermal Growth Factor: A Review on Theory and Research Methods
Authors: Mohamad H. Shahrajabian and Wenli SunThe most abundant protein found in mammals is collagen, and there are around 28 different types of collagen found in the human body, but there are five types, namely, Type I, Type II, Type III, Type V, and Type X, most generally applied in supplements, and the five common types of collagen are available in various forms and form different sources, which result in various potential benefits. The epidermal growth factor is one Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
